Detalhe da pesquisa
1.
The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL.
Blood;
119(14): 3276-84, 2012 Apr 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22337718
2.
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
Lancet Oncol;
9(2): 105-16, 2008 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18226581
3.
Treatment strategies in follicular lymphomas: current status and future perspectives.
J Clin Oncol;
23(26): 6394-9, 2005 Sep 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16155025
4.
Use of polymorphisms in the noncoding region of the human mitochondrial genome to identify potential contamination of human leukemia-lymphoma cell lines.
Hematol J;
5(1): 61-8, 2004.
Artigo
em Inglês
| MEDLINE
| ID: mdl-14745432
5.
Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Cancer;
107(5): 1014-22, 2006 Sep 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16878325
6.
Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell.
Blood;
101(2): 699-702, 2003 Jan 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12393524